Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves LivaNova’s device combo to treat drug-resistant epilepsy

fiercebiotechOctober 10, 2017

Tag: FDA , LivaNova , drug-resistant epilepsy

PharmaSources Customer Service